淋巴结转移空间指标优化T1-T2期食管鳞癌预后分层
该回顾性队列纳入185例T1-T2期食管鳞癌且病理证实淋巴结转移并接受根治性食管切除术的患者,定义最大淋巴结转移距离为肿瘤至最远转移淋巴结的直线距离、跨区播散为肿瘤与最远淋巴结间解剖分区边界数。结果显示转移距离>45 mm和跨区播散均为独立预后因素,提示空间指标可补充单纯淋巴结计数用于风险分层。
要点
- 淋巴结转移距离>45 mm是T1-T2期食管鳞癌独立不良预后因素。
- 跨区播散(Δ1+Δ2)患者总生存和无病生存显著更差。
- 空间指标可补充淋巴结计数,改善T1-T2期食管鳞癌风险分层。
核心结论
- 在T1-T2期食管鳞癌中,转移距离和跨区播散提供独立于单纯淋巴结计数的预后信息。
- 将空间指标纳入分期可能改善风险分层并指导治疗决策。
研究设计与样本
- 回顾性队列研究,纳入185例T1-T2期食管鳞癌且病理证实淋巴结转移并接受根治性食管切除术的患者。
- 定义最大淋巴结转移距离为肿瘤至最远转移淋巴结的直线距离,跨区播散(Δ)为肿瘤与最远淋巴结间解剖分区边界数。
- 采用Kaplan-Meier法和多因素Cox回归评估生存结局。
主要发现
- X-tile分析确定45 mm为淋巴结转移距离最佳截断值,超过该值总生存显著降低(log-rank P < .001)。
- 多因素分析中,N2分期(HR 5.13;95%CI 1.47-17.91;P = .010)和转移距离>45 mm(HR 2.06;95%CI 1.07-3.96;P = .030)均为死亡的独立预测因素。
- 51.9%的患者观察到跨区播散。
- Δ1+Δ2受累患者的总生存(P = .004)和无病生存(P = .034)显著差于Δ0患者。
- 多因素分析证实Δ1+Δ2为独立预后因素(HR 1.93;95%CI 1.01-3.67;P = .045)。
临床怎么用
- 对T1-T2期食管鳞癌伴淋巴结转移患者,可评估转移距离和跨区播散以细化预后分层。
- 转移距离>45 mm或存在跨区播散提示更高死亡风险,可能需强化治疗决策。
局限性
- 回顾性队列设计,样本量185例,可能存在选择偏倚。
- 空间指标截断值45 mm基于X-tile分析,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine whether the spatial extent of lymph node metastases (LNM) predicts survival in early esophageal squamous cell carcinoma (ESCC). METHODS: A retrospective cohort of 185 patients with T1-T2 ESCC and pathologically confirmed LNM who underwent radical esophagectomy were enrolled in this study. We defined maximal LNM distance as the linear distance from the tumor to the farthest metastatic lymph node and cross-zonal dissemination (Δ) as the number of anatomical zonal boundaries between the tumor and the farthest node. Survival outcomes were assessed by Kaplan-Meier and multivariable Cox regression. RESULTS: X-tile analysis identified 45 mm as the optimal cutoff for LNM distance, above which overall survival was significantly reduced (log-rank P < .001). On multivariable analysis, both N2 stage (hazard ratios [HR], 5.13; 95% confidence interval [CI], 1.47-17.91; P = .010) and LNM distance >45 mm (HR, 2.06; 95% CI, 1.07-3.96; P = .030) were independent predictors of mortality. Cross-zonal dissemination was observed in 51.9% of patients. Moreover, patients with Δ1+Δ2 involvement exhibited significantly worse overall and disease-free survival compared with those with Δ0 (overall survival P = .004; disease-free survival P = .034). Multivariable analysis confirmed Δ1+Δ2 as an independent prognostic factor (HR, 1.93; 95% CI, 1.01-3.67; P = .045). CONCLUSIONS: In T1-T2 ESCC, both metastatic distance and cross-zonal dissemination provide independent prognostic information beyond simple lymph node counts. Therefore, incorporating spatial metrics into staging may improve risk stratification and guide treatment decisions.
引用
- Lin C, Chen M, Huang Y, et al. Spatial metrics of lymph node metastasis refine prognostic stratification of T1-T2 esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2025. PMID: 41270860. doi:10.1016/j.jtcvs.2025.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。